AHCOAdaptHealth Corp.

Nasdaq adapthealth.com


$ 9.23 $ -0.38 (-3.95 %)    

Thursday, 09-May-2024 12:39:30 EDT
QQQ $ 440.82 $ 0.36 (0.08 %)
DIA $ 392.27 $ 1.62 (0.41 %)
SPY $ 518.99 $ 1.55 (0.3 %)
TLT $ 90.05 $ 0.01 (0.01 %)
GLD $ 215.90 $ 1.20 (0.56 %)
$ 9.69
$ 9.61
$ 0.00 x 0
$ 9.23 x 100
$ 9.21 - $ 9.64
$ 6.37 - $ 15.37
1,744,653
na
1.29B
$ 0.82
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 02-27-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 03-16-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-07-2020 06-30-2020 10-Q
17 05-08-2020 03-31-2020 10-Q
18 03-06-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 07-31-2019 06-30-2019 10-Q
21 05-14-2019 03-31-2019 10-Q
22 03-29-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 adapthealth-q1-2024-gaap-eps-002-may-not-be-comparable-to-005-estimate-sales-792497m-beat-769867m-estimate

AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.05 b...

 adapthealth-appoints-suzanne-foster-as-chief-executive-officer-will-assume-leadership-of-the-company-from-interim-ceo-and-chairman-of-the-board-richard-barasch-on-may-20-2024

AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-center...

 rbc-capital-reiterates-outperform-on-adapthealth-maintains-13-price-target

RBC Capital analyst Ben Hendrix reiterates AdaptHealth (NASDAQ:AHCO) with a Outperform and maintains $13 price target.

 ubs-maintains-buy-on-adapthealth-raises-price-target-to-13

UBS analyst Whit Mayo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $9 to $13.

 truist-securities-maintains-buy-on-adapthealth-raises-price-target-to-13

Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $1...

 why-helix-energy-solutions-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

 norwegian-cruise-line-posts-strong-sales-joins-hims--hers-health-sterling-infrastructure-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Tuesday.

 earnings-scheduled-for-february-27-2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

 ubs-maintains-buy-on-adapthealth-lowers-price-target-to-9

UBS analyst Whit Mayo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $10 to $9.

 why-carmax-shares-are-trading-higher-by-around-8-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.

 rbc-capital-maintains-outperform-on-adapthealth-lowers-price-target-to-13

RBC Capital analyst Ben Hendrix maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $18 t...

 truist-securities-maintains-buy-on-adapthealth-lowers-price-target-to-11-report-released-on-7th-nov

Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $1...

 b-of-a-securities-downgrades-adapthealth-to-underperform-announces-65-price-target

B of A Securities analyst Kevin Fischbeck downgrades AdaptHealth (NASDAQ:AHCO) from Neutral to Underperform and announces $6...

 truist-securities-maintains-buy-on-adapthealth-lowers-price-target-to-11

Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $1...

 why-adapthealth-stock-trading-is-lower-today

AdaptHealth Corp (NASDAQ: AHCO) reported third-quarter net revenue of $804.0 million, up 6.3% Y/Y, beating the 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION